Open Access

Voice-based screening for SARS-CoV-2 exposure in cardiovascular clinics

logo

Date: 16 June 2021
Journal: European Heart Journal - Digital Health , Volume 2 , Issue 3 , Pages 521 - 527
Authors: A. Sharma , E. Oulousian , J. Ni , R. Lopes , M. Cheng , J. Label , F. Henriques , C. Lighter , N. Giannetti , R. Avram

ESC Journals

AbstractAims

Artificial intelligence (A.I) driven voice-based assistants may facilitate data capture in clinical care and trials; however, the feasibility and accuracy of using such devices in a healthcare environment are unknown. We explored the feasibility of using the Amazon Alexa (‘Alexa’) A.I. voice-assistant to screen for risk factors or symptoms relating to SARS-CoV-2 exposure in quaternary care cardiovascular clinics.

Methods and results

We enrolled participants to be screened for signs and symptoms of SARS-CoV-2 exposure by a healthcare provider and then subsequently by the Alexa. Our primary outcome was interrater reliability of Alexa to healthcare provider screening using Cohen’s Kappa statistic. Participants rated the Alexa in a post-study survey (scale of 1 to 5 with 5 reflecting strongly agree). This study was approved by the McGill University Health Centre ethics board. We prospectively enrolled 215 participants. The mean age was 46 years [17.7 years standard deviation (SD)], 55% were female, and 31% were French speakers (others were English). In total, 645 screening questions were delivered by Alexa. The Alexa mis-identified one response. The simple and weighted Cohen’s kappa statistic between Alexa and healthcare provider screening was 0.989 [95% confidence interval (CI) 0.982–0.997] and 0.992 (955 CI 0.985–0.999), respectively. The participants gave an overall mean rating of 4.4 (out of 5, 0.9 SD).

Conclusion

Our study demonstrates the feasibility of an A.I. driven multilingual voice-based assistant to collect data in the context of SARS-CoV-2 exposure screening. Future studies integrating such devices in cardiovascular healthcare delivery and clinical trials are warranted.

Registration

https://clinicaltrials.gov/ct2/show/NCT04508972.

About the contributors

Abhinav Sharma

Montreal (McGill University Health Centre)

Role: Author

Emily Oulousian

Role: Author

Jiayi Ni

Role: Author